Family Physicians' Barriers and Facilitators in Incorporating Medication Abortion

被引:7
|
作者
Razon, Na'amah [1 ]
Wulf, Sarah [2 ]
Perez, Citlali [2 ]
McNeil, Sarah [3 ,4 ]
Maldonado, Lisa [5 ]
Fields, Alison Byrne [6 ]
Holt, Kelsey [2 ]
Fox, Edith [2 ]
Silverstein, Ilana [2 ]
Dehlendorf, Christine [2 ]
机构
[1] Univ Calif Davis, Dept Family & Community Med, 4860 Y St,Suite 2300, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, Dept Family & Community Med, Person Ctr Reprod Hlth Program, San Francisco, CA USA
[3] Costa Reg Med Ctr, Dept Family Med, Martinez, CA USA
[4] Costa Reg Med Ctr, Dept Ob Gyn, Martinez, CA USA
[5] Reprod Hlth Access Project, New York, NY USA
[6] Aggregate, Seattle, WA USA
关键词
Contraception; Drug-Induced Abortion; Family Medicine; Family Physicians; Health Policy; Health Services Accessibility; Mifepristone; Patient-Centered Care; Primary Health Care; Qualitative Research; Reproductive Health; Scope of Practice; SERVICE AVAILABILITY; UNITED-STATES; MANAGEMENT;
D O I
10.3122/jabfm.2022.03.210266
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Medication abortion (MAB) provision by family physicians has the potential to expand abortion access. However, there are documented individual and structural barriers to provision. This study investigates how family physicians in the United States (US) navigate the barriers impeding abortion provision in primary care. Methods: We conducted a qualitative study on the experiences of US family physicians with MAB in primary care. We recruited participants at national conferences and via professional networks. This analysis focuses on the experiences of the subset of participants who expressed interest in providing MAB. Results: Forty-eight participants met inclusion criteria, with representation from all 4 regions of the US. Participants had diverse experiences related to abortion provision, training, and the environment in which they practice, with a third of participants working in states with hostile abortion policies. We categorized participants into 3 groups: (1) doctors who did not receive training and do not provide abortions (n = 11), (2) doctors who received training but do not provide abortions (n = 20), and (3) doctors who received training and currently provide abortions (n = 17). We found that training, administrative and community support, and internal motivation to overcome barriers help family physicians integrate MAB in primary care practices. Federal and state laws, absence of training, stigma around abortion provision, inaccurate or limited knowledge of institutional barriers, and administrative resistance all contributed to doctors excluding abortion provision from their scope of practice. Conclusion: Improving medication abortion provision by family physicians requires addressing the individual and system barriers family physicians encounter so they receive the education, training, and support to successfully integrate abortion care into clinical practice.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 50 条
  • [1] Medication abortion and family physicians' scope of practice
    Prine, LW
    Lesnewski, R
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE, 2005, 18 (04): : 304 - 306
  • [2] Facilitators and barriers in communicating medication adherence appraisal electronically to physicians
    Dietrich, Fine
    Zeller, Andreas
    Hersberger, Kurt E.
    Arnet, Isabelle
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 795 - 795
  • [3] Medication Reconciliation: Barriers and Facilitators from the Perspectives of Resident Physicians and Pharmacists
    Boockvar, Kenneth S.
    Santos, Susan L.
    Kushniruk, Andre
    Johnson, Christopher
    Nebeker, Jonathan R.
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2011, 6 (06) : 329 - 337
  • [4] Barriers to and Enablers of Abortion Provision for Family Physicians Trained in Abortion During Residency
    Summit, Aleza K.
    Lague, Ian
    Dettmann, Miranda
    Gold, Marji
    [J]. PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2020, 52 (03) : 151 - 159
  • [5] Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan
    Nguyen, Teresa
    Bareham, Julia
    Halpape, Katelyn
    [J]. CANADIAN FAMILY PHYSICIAN, 2024, 70 (04) : e52 - e60
  • [6] Partner notification by family physicians for sexually transmitted infections Facilitators and barriers
    Choi, Alexandra
    Campbell, Audrey
    Consolacion, Theodora
    Pawa, Jasmine
    Ng, Brian
    Wong, Jason
    [J]. CANADIAN FAMILY PHYSICIAN, 2022, 68 (06) : E182 - E189
  • [7] Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians
    Butalia, Sonia
    Lee-Krueger, Rachelle C. W.
    Mcbrien, Kerry A.
    Leung, Alexander A. C.
    Anderson, Todd J.
    Quan, Hude
    Naugler, Christopher
    Chen, Guanmin
    Campbell, David J. T.
    [J]. CJC OPEN, 2020, 2 (06) : 530 - 538
  • [8] Barriers to and Facilitators of Medication Adherence
    Rolnick, Sharon J.
    Asche, Steve
    Pawloski, Pamala A.
    Bruzek, Richard J.
    Hedblom, Brita
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2013, 5 (05) : 209 - 215
  • [9] Facilitators and Barriers to Expedited Partner Therapy: Results From a Survey of Family Physicians
    Wong, Jason
    Zakher, Bernadette
    Consolacion, Theodora
    Leong, Jeffrey
    Choi, Alexandra
    Prescott, Cheryl
    Ng, Brian
    Pawa, Jasmine
    Campbell, Audrey
    [J]. SEXUALLY TRANSMITTED DISEASES, 2020, 47 (08) : 525 - 529
  • [10] Facilitators and Barriers to Interprofessional Teamwork within Family Medicine Practices: Physicians' Perspectives
    Bell, Neil
    Szafran, Olga
    Robertson, Sandra
    Williams, Beverly
    [J]. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2014, 13 : 481 - 481